Eli Lilly (LLY) Targets Black-Market Sales of Unapproved Weight-Loss Drug in Legal Battle

Eli Lilly (LLY) initiates lawsuits against six companies over illegal sales of retatrutide, an experimental obesity treatment not yet FDA-approved.

The post Eli Lilly (LLY) Targets Black-Market Sales of Unapproved Weight-Loss Drug in Legal Battle appeared first on Blockonomi.